TrialBMC nephrology2022

An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis.

Anna Wasilewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.